Smith Julie is a director of Stoke Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Stoke Therapeutics, Inc.
15 Jun 23
4
EXELIXIS, INC.
2 Jun 23
4
Stoke Therapeutics, Inc.
8 Jun 22
4
EXELIXIS, INC.
27 May 22
4
Stoke Therapeutics, Inc.
25 Jun 21
4
EXELIXIS, INC.
28 May 21
4
Stoke Therapeutics, Inc.
5 Jun 20
3
Stoke Therapeutics, Inc.
5 Jun 20
4
EXELIXIS, INC.
22 May 20
4
Audentes Therapeutics, Inc.
15 Jan 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 23 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 12.46 | 19,441 | 242.23 k | 19,441 |
1 Jun 23 | EXEL Exelixis | Option Common Stock | Grant | Acquire A | No | No | 19.39 | 44,087 | 854.85 k | 44,087 |